Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

LiDCO Monitor Study

This study has been completed.
Information provided by (Responsible Party):
Joseph D. Tobias, Nationwide Children's Hospital Identifier:
First received: March 26, 2012
Last updated: March 16, 2016
Last verified: March 2016
Results First Received: March 16, 2016  
Study Type: Interventional
Study Design: Endpoint Classification: Safety/Efficacy Study;   Intervention Model: Single Group Assignment;   Masking: Open Label;   Primary Purpose: Diagnostic
Condition: Cardiac Surgery
Intervention: Device: LiDCO rapid monitor

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
LiDCO Rapid Monitor No text entered.

Participant Flow:   Overall Study
    LiDCO Rapid Monitor  
STARTED     30  
COMPLETED     30  

  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
LiDCO Rapid Monitor No text entered.

Baseline Measures
    LiDCO Rapid Monitor  
Number of Participants  
[units: participants]
[units: participants]
<=18 years     16  
Between 18 and 65 years     14  
>=65 years     0  
[units: years]
Mean (Standard Deviation)
  21.5  (11.018)  
[units: participants]
Female     15  
Male     15  
Region of Enrollment  
[units: participants]
United States     30  

  Outcome Measures
  Show All Outcome Measures

1.  Primary:   Difference in Pulse Pressure Variability From Baseline to Post-ANH   [ Time Frame: 1 Day ]

2.  Secondary:   Difference in Stroke Volume Variability From Baseline to Post ANH.   [ Time Frame: 1 Day ]

  Serious Adverse Events

  Other Adverse Events

  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.

  More Information
  Hide More Information

Certain Agreements:  
All Principal Investigators ARE employed by the organization sponsoring the study.

Results Point of Contact:  
Name/Title: Joseph D. Tobias, MD
Organization: Nationwide Children's Hospital
phone: 614-722-4200

Responsible Party: Joseph D. Tobias, Nationwide Children's Hospital Identifier: NCT01567371     History of Changes
Other Study ID Numbers: IRB12-00096
Study First Received: March 26, 2012
Results First Received: March 16, 2016
Last Updated: March 16, 2016
Health Authority: United States: Institutional Review Board